Oncolytics Biotech Inc (ONCY)
1.08
+0.02
(+1.89%)
USD |
NASDAQ |
Apr 25, 16:00
1.08
0.00 (0.00%)
After-Hours: 16:49
Oncolytics Biotech EPS Diluted (TTM): -0.3046 for Dec. 31, 2023
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.3046 |
| September 30, 2023 | -0.3783 |
| June 30, 2023 | -0.3353 |
| March 31, 2023 | -0.3165 |
| December 31, 2022 | -0.3368 |
| September 30, 2022 | -0.3375 |
| June 30, 2022 | -0.3476 |
| March 31, 2022 | -0.3831 |
| December 31, 2021 | -0.3909 |
| September 30, 2021 | -0.4487 |
| June 30, 2021 | -0.4973 |
| March 31, 2021 | -0.5141 |
| December 31, 2020 | -0.4413 |
| September 30, 2020 | -0.9012 |
| June 30, 2020 | -0.9023 |
| March 31, 2020 | -0.9739 |
| December 31, 2019 | -1.147 |
| September 30, 2019 | -0.7301 |
| June 30, 2019 | -0.762 |
| March 31, 2019 | -0.777 |
| December 31, 2018 | -0.8194 |
| September 30, 2018 | -0.8593 |
| June 30, 2018 | -0.8658 |
| March 31, 2018 | -0.8945 |
| December 31, 2017 | -0.8642 |
| Date | Value |
|---|---|
| September 30, 2017 | -0.9423 |
| June 30, 2017 | -1.001 |
| March 31, 2017 | -0.9109 |
| December 31, 2016 | -0.9033 |
| September 30, 2016 | -0.787 |
| June 30, 2016 | -0.7137 |
| March 31, 2016 | -0.798 |
| December 31, 2015 | -0.8973 |
| September 30, 2015 | -1.018 |
| June 30, 2015 | -1.309 |
| March 31, 2015 | -1.513 |
| December 31, 2014 | -1.723 |
| September 30, 2014 | -2.022 |
| June 30, 2014 | -2.226 |
| March 31, 2014 | -2.348 |
| December 31, 2013 | -2.585 |
| September 30, 2013 | -3.006 |
| June 30, 2013 | -3.510 |
| March 31, 2013 | -4.176 |
| December 31, 2012 | -4.465 |
| September 30, 2012 | -4.896 |
| June 30, 2012 | -4.624 |
| March 31, 2012 | -4.383 |
| December 31, 2011 | -3.918 |
| September 30, 2011 | -3.839 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (TTM) Range, Past 5 Years
-1.147
Minimum
Dec 2019
-0.3046
Maximum
Dec 2023
-0.5499
Average
-0.4413
Median
Dec 2020
EPS Diluted (TTM) Benchmarks
| Acasti Pharma Inc | -4.578 |
| Aurinia Pharmaceuticals Inc | -0.53 |
| Edesa Biotech Inc | -2.639 |
| Lexaria Bioscience Corp | -0.68 |
| Xenon Pharmaceuticals Inc | -2.72 |